+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Prosthetic Heart Valves - Global Market Trajectory & Analytics

  • PDF Icon

    Report

  • 297 Pages
  • October 2022
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 1824155

Global Prosthetic Heart Valves Market to Reach $9.4 Billion by 2027

Amid the COVID-19 crisis, the global market for Prosthetic Heart Valves estimated at US$6.1 Billion in the year 2020, is projected to reach a revised size of US$9.4 Billion by 2027, growing at a CAGR of 6.5% over the period 2020-2027. Transcatheter Heart Valves, one of the segments analyzed in the report, is projected to record a 9.3% CAGR and reach US$5.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Tissue Heart Valves segment is readjusted to a revised 6.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $2.5 Billion, While China is Forecast to Grow at 8.5% CAGR

The Prosthetic Heart Valves market in the U.S. is estimated at US$2.5 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$906.1 Million by the year 2027 trailing a CAGR of 8.5% over the period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.3% and 6.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$593.2 Million by the year 2027.

Mechanical Heart Valves Segment to Record -5.2% CAGR

In the global Mechanical Heart Valves segment, USA, Canada, Japan, China and Europe will drive the -5.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$811.2 Million in the year 2020 will reach a projected size of US$498.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 0.5% CAGR through the analysis period.

Select Competitors (Total 28 Featured)

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Colibri Heart Valve LLC
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • JenaValve Technology, Inc.
  • Lepu Medical Technology Co. Ltd
  • LivaNova PLC
  • Medtronic plc
  • Micro Interventional Devices, Inc.

What's New for 2022?

  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to a digital archives and Research Platform
  • Complimentary updates for one year
Frequently Asked Questions about the Global Market for Prosthetic Heart Valves

What is the estimated value of the Global Market for Prosthetic Heart Valves?

The Global Market for Prosthetic Heart Valves was estimated to be valued at $6.1 Billion in 2020.

What is the growth rate of the Global Market for Prosthetic Heart Valves?

The growth rate of the Global Market for Prosthetic Heart Valves is 6.4%, with an estimated value of $9.4 Billion by 2027.

What is the forecasted size of the Global Market for Prosthetic Heart Valves?

The Global Market for Prosthetic Heart Valves is estimated to be worth $9.4 Billion by 2027.

Who are the key companies in the Global Market for Prosthetic Heart Valves?

Key companies in the Global Market for Prosthetic Heart Valves include Abbott Laboratories, Boston Scientific Corporation, Colibri Heart Valve LLC, CryoLife, Inc., Edwards Lifesciences Corporation, JenaValve Technology, Inc., Lepu Medical Technology Co. Ltd, LivaNova PLC and Micro Interventional Devices, Inc..

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of COVID-19 Pandemic and Looming Global Recession
  • Study Demonstrates Greater Susceptibility of TAVR Patients with Blood Group A to COVID-19
  • Heart Valves: Essential for Blood Flow Control
  • Heart Valve Disorders & Diagnosis
  • Replacement or Repair: Treatment Options for Diseased Heart Valves
  • An Introduction to Prosthetic Heart Valves
  • Types of Prosthetic Heart Valves
  • Prosthetic Heart Valves: Global Market Outlook
  • Growing Prevalence of Valvular Heart Disease: An Opportunity for the Market
  • Transcatheter Heart Valves Segment Continues to Boost Market Prospects
  • Developed Regions Lead, Developing Economies to Spearhead Future Growth
  • Competition
  • Global Heart Valves Market Breakdown by Value Sales (in %) for Leading Players: 2019
  • Transcatheter Aortic Valve Replacement Market Breakdown (in %) by Leading Players for 2019
  • World Brands
  • Recent Market Activity
  • Prosthetic Heart Valves - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Aging Demographics and Resultant Rise in Cardiac Disease Drives Market
  • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
  • Life Expectancy at Age 60 and 80 Years: (2010-2015), (2020-2025) & (2045-2050)
  • Global Annual Medical Cost of CVD in US$ Billion: 2010, 2015, 2020, 2025 and 2030
  • Sutureless Valves: Potential Substitutes for Conventional Stentless and Stented Biological Valves
  • Growing Interest in Bioprosthetic Valves across Developed Regions
  • Biological Valves: Continuous Improvements Present Growth Opportunities
  • Artificial Mechanical Heart Valves Come of Age
  • Transcatheter Aortic Valve Replacement (TAVR): Poised for High Growth
  • Expanding Indications & New Valves to Boost TAVR Growth
  • Transcatheter Mitral Valve Regurgitation Treatment Faces Hurdles
  • Pediatric Heart Valve Disease: Choosing Between Repair and Replacement
  • An Insight into Mechanical and Biological Valve Prosthesis
  • Mechanical Vs Biological Heart Valves: A Review
  • Noise Emanated by Mechanical Heart Valves May Lead to Insomnia among Recipients
  • Safety Concerns Shifts Focus towards Stentless Valves
  • Tissue Engineered Aortic Valves: The Future
  • Innovations & Advancements in Heart Valve Market to Propel Growth
  • PoliValve: A New Artificial Heart Valve that is both Durable and Biocompatible
  • Using AI to Customize Prosthetic Heart Valves
  • A Novel Copolymer-based Material to Make Sturdier Artificial Heart Valves
  • Expandable Biomimetic Replacement Heart Valve
  • 3D Printed Heart Valves to Improve TAVR Outcomes
  • MitraClip, Caisson Set to Revolutionize the Valve Space
  • Meril Life Sciences Offers Bioprosthetic Valve
  • Polymer Heart Valves: Potential to Improve Outcomes & Reduced Costs
  • Knitting and Weaving Technologies to Develop Heart Valve Fabric
  • Rise in Healthcare Expenditure Bodes Well for the Market
  • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
  • Elderly Healthcare Expenditure as a % of GDP for the US, Europe and Japan for 1970, 2010 and 2050
  • Failure of Prosthetic Heart Valve: A Key Concern
  • Symptoms of Malfunctioning Prosthetic Heart Valve
  • Prosthetic Valve Endocarditis (PVE)
  • Prosthetic Valve Thrombosis (PVT)
  • Embolization
  • Structural Breakdown of Bioprosthetic Valves
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 2: World Historic Review for Prosthetic Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
  • Table 3: World 11-Year Perspective for Prosthetic Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2016, 2021 & 2027
  • Table 4: World Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 5: World Historic Review for Transcatheter Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
  • Table 6: World 11-Year Perspective for Transcatheter Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2021 & 2027
  • Table 7: World Recent Past, Current & Future Analysis for Tissue Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 8: World Historic Review for Tissue Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
  • Table 9: World 11-Year Perspective for Tissue Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2021 & 2027
  • Table 10: World Recent Past, Current & Future Analysis for Mechanical Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 11: World Historic Review for Mechanical Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
  • Table 12: World 11-Year Perspective for Mechanical Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2021 & 2027
  • Table 13: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 14: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
  • Table 15: World 11-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2021 & 2027
  • Table 16: World Recent Past, Current & Future Analysis for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 17: World Historic Review for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
  • Table 18: World 11-Year Perspective for Ambulatory Surgical Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2021 & 2027
  • Table 19: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 20: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR
  • Table 21: World 11-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2021 & 2027
III. MARKET ANALYSIS
UNITED STATES
  • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
  • Market Overview
  • Deaths due to Valvular Heart Disease: Percentage Breakdown by Valve Disease
  • Number of TAVR Procedures in the US for the Years 2012-2019
  • Aging Population Enhances Risk of Heart Valve Disease, Driving Market Growth
  • US Population by Age Group (in %) for 2018, 2030 & 2050
  • North American Aging Population (in Thousands) by Age Group: 1975-2050
  • Minimally Invasive Surgeries for Aortic Stenosis Treatment Gain Popularity
  • Valve Type and Age: Critical Factors Impacting Success of Heart Valve Replacement Surgery
  • Expanded Indications for Transcatheter Heart Valves
CANADA
JAPAN
  • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
  • Market Overview
CHINA
  • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
  • Market Overview
EUROPE
  • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
  • Market Overview
  • A Peek into the European TAVI Adoption Potential
  • Competition
  • European TAVR Market Breakdown by Leading Competitors (in %) for 2019
FRANCE
  • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
GERMANY
  • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
ITALY
UNITED KINGDOM
  • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
AUSTRALIA
  • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)
INDIA
  • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
  • Heart Valve Market in India: Attractive Opportunities in Store
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
BRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)
AFRICA
  • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)
IV. COMPETITION
  • Total Companies Profiled: 28

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Colibri Heart Valve LLC
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • JenaValve Technology, Inc.
  • Lepu Medical Technology Co. Ltd
  • LivaNova PLC
  • Medtronic plc
  • Micro Interventional Devices, Inc.